Press Resease

Radiotherapy Market by Product (External Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiation Therapy), By Technology for Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, Colorectal cancer, Gynecological Cancer, Penile Cancer and Other Cancer: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Published Date: 10-Mar-2017 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-1296 Status : Published

Global Radiotherapy Market is growing at a CAGR of 6.8%, to reach USD 8.53 Billion by 2022.

Description

The report covers forecast and analysis for the radiotherapy market on a global and regional level. The study provides historic data from 2014 along with a forecast for 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the radiotherapy market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the radiotherapy market on a global level.

In order to give the users of this report a comprehensive view on the radiotherapy market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product, technology, and applications segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis.

The study provides a decisive view on the radiotherapy market by segmenting the market based on product, technology, applications, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022. Based on product, radiotherapy market has been segmented into external beam radiation therapy, internal radiation therapy (brachytherapy), and systemic radiation therapy. External beam radiation therapy is further sub-segmented into compact advanced radiotherapy systems (Cyberknife, Gamma knife, and Tomotherapy), proton therapy systems (Cyclotron and Synchrotron) and electron emitting high energy linear accelerators (Linac). Internal radiation therapy is further sub-classified into seeds, applicators & after leaders and electronic brachytherapy. External beam radiation therapy holds the maximum share of global radiotherapy market.

Based on technology radiotherapy market is classified into external beam radiation therapy (Image-Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, Tomotherapy, 3D Conformal Radiotherapy (3D CRT) and Volumetric Modulated Arc Therapy (VMAT)), internal radiation therapy (Low Dose Rate and High Dose Rate), and systemic radiation therapy.

Based on applications external beam radiation therapy segment is classified into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer and other. Internal radiation therapy is classified into prostate cancer, gynecological cancer, breast cancer, penile cancer and other.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for radiotherapy based on individual segment and applications in all the regions and countries.

The report also includes detailed profiles of end players such as Elekta AB, Varian Medical Systems, Accuray Incorporated, IBA Worldwide, IsoRay Medical, Inc., Nordion, Inc., Raysearch Laboratories, Mevion Medical Systems, Mitsubishi Electric Corporation and C. R. Bard, Inc. among others.

This report segments the global radiotherapy market as follows:

Global Radiotherapy Market: By Product

  • External beam radiation therapy
  • Compact Advanced Radiotherapy Systems
    • Cyberknife
    • Gamma Knife
    • Tomotherapy
  • Proton Therapy Systems
    • Cyclotron
    • Synchrotron
  • Electron Emitting High Energy Linear Accelerators (Linac)
  • Internal Radiation Therapy/Brachytherapy
  • Seeds
  • Applicators & Afterloaders
  • Electronic Brachytherapy
  • Systemic Radiation Therapy

Global Radiotherapy Market: By Technology

  • External Beam Radiation Therapy
  • Image-Guided Radiotherapy (IGRT)
  • Intensity Modulated Radiotherapy (IMRT)
  • Stereotactic Technology
  • Proton Beam Therapy
  • Tomotherapy
  • 3D Conformal Radiotherapy (3D CRT)
  • Volumetric Modulated Arc Therapy (VMAT)
  • Internal Beam Radiotherapy
  • Low Dose Rate
  • High Dose Rate
  • Systemic Radiation Therapy

Global Radiotherapy Market: By Application

  • External Beam Radiation Therapy
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head & Neck Cancer
  • Colorectal Cancer
  • Other
  • Internal Radiation Therapy
  • Prostate Cancer
  • Gynecological Cancer
  • Breast Cancer
  • Penile Cancer
  • Other

Global Radiotherapy Market: By Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global radiotherapy market, 2014 – 2022 (USD Billion)
    • 2.2. Global radiotherapy market : Snapshot
  • Chapter 3. Radiotherapy– Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global radiotherapy market drivers: Impact analysis
      • 3.2.2. Increasing incidences of cancer
      • 3.2.3. Increasing geriatric population
    • 3.3. Market restraints
      • 3.3.1. Global radiotherapy market restraints: Impact analysis
      • 3.3.2. Lack of infrastructure
    • 3.4. Opportunities
      • 3.4.1. Technological advancements in radiotherapy products
    • 3.5. Porter’s five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product segment
      • 3.6.2. Market attractiveness analysis, by technology segment
      • 3.6.3. Market attractiveness analysis, by applications segment
      • 3.6.4. Market attractiveness analysis, by regional segment
  • Chapter 4. Global Radiotherapy Market – Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global radiotherapy market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  • Chapter 5. Global Radiotherapy Market – Product Segment Analysis
    • 5.1. Global radiotherapy market: Product overview
      • 5.1.1. Global radiotherapy market revenue share, by Product, 2016 and 2022
    • 5.2. External beam radiation therapy
      • 5.2.1. Global External beam radiation therapy market, 2014 – 2022(USD Billion)
      • 5.2.2. Compact Advanced Radiotherapy Systems
        • 5.2.2.1. Global Compact Advanced Radiotherapy Systems market , 2014 – 2022(USD Billion)
        • 5.2.2.2. Global Cyberknife market, 2014 – 2022(USD Billion)
        • 5.2.2.3. Global Gamma knife market, 2014 – 2022(USD Billion)
        • 5.2.2.4. Global Tomotherapy market, 2014 – 2022(USD Billion)
      • 5.2.3. Proton Therapy Systems
        • 5.2.3.1. Global Proton Therapy Systems market, 2014 – 2022(USD Billion)
        • 5.2.3.2. Global Cyclotron market, 2014 – 2022(USD Billion)
        • 5.2.3.3. Global Synchrotron market, 2014 – 2022(USD Billion)
      • 5.2.4. Electron Emitting High Energy Linear Accelerators (Linac)
        • 5.2.4.1. Global Electron Emitting High Energy Linear Accelerators (Linac) market, 2014 – 2022(USD Billion)
    • 5.3. Internal Radiation Therapy/Brachytherapy
      • 5.3.1. Global Internal Radiation Therapy/Brachytherapy market, 2014 – 2022(USD Billion)
      • 5.3.2. Global seeds market, 2014 – 2022(USD Billion)
      • 5.3.3. Global Applicators & Afterloaders market, 2014 – 2022(USD Billion)
      • 5.3.4. Global Electronic Brachytherapy market, 2014 – 2022(USD Billion)
    • 5.4. Systemic Radiation Therapy
      • 5.4.1. Global Systemic Radiation Therapy market, 2014 – 2022(USD Billion)
  • Chapter 6. Global Radiotherapy Market – Technology Segment Analysis
    • 6.1. Global radiotherapy market: Technology overview
      • 6.1.1. Global radiotherapy market revenue share, by technology, 2014 and 2020
    • 6.2. External beam radiation therapy
      • 6.2.1. Global External beam radiation therapy market , 2014 – 2022(USD Billion)
      • 6.2.2. Global Image-Guided Radiotherapy (IGRT) market, 2014 – 2022(USD Billion)
      • 6.2.3. Global Intensity Modulated Radiotherapy (IMRT) market, 2014 – 2022(USD Billion)
      • 6.2.4. Global Stereotactic Technology market, 2014 – 2022(USD Billion)
      • 6.2.5. Global Proton Beam Therapy market, 2014 – 2022(USD Billion)
      • 6.2.6. Global Tomotherapy market, 2014 – 2022(USD Billion)
      • 6.2.7. Global 3D Conformal Radiotherapy (3D CRT) market, 2014 – 2022(USD Billion)
      • 6.2.8. Global Volumetric Modulated Arc Therapy (VMAT) market, 2014 – 2022(USD Billion)
    • 6.3. Internal Radiation Therapy
      • 6.3.1. Global Internal radiation therapy market, 2014 – 2022(USD Billion)
      • 6.3.2. Global Low Dose Rate Radiotherapy market , 2014 – 2022 (USD Billion)
      • 6.3.3. Global High Dose Rate Radiotherapy market , 2014 – 2022 (USD Billion)
    • 6.4. Systemic Radiation Therapy
      • 6.4.1. Global Systemic Radiation Therapy market, 2014 – 2022(USD Billion)
  • Chapter 7. Global Radiotherapy Market – Application Segment Analysis
    • 7.1. Global radiotherapy market: Application overview
      • 7.1.1. Global radiotherapy market revenue share, by application, 2014 and 2020
    • 7.2. External beam radiation therapy
      • 7.2.1. Global External beam radiation therapy market for prostate cancer, 2014 – 2022(USD Billion)
      • 7.2.2. Global External beam radiation therapy market for breast cancer, 2014 – 2022(USD Billion)
      • 7.2.3. Global External beam radiation therapy market for lung cancer, 2014 – 2022(USD Billion)
      • 7.2.4. Global External beam radiation therapy market for head & neck cancer, 2014 – 2022(USD Billion)
      • 7.2.5. Global External beam radiation therapy market for colorectal cancer, 2014 – 2022(USD Billion)
      • 7.2.6. Global External beam radiation therapy market for other cancers, 2014 – 2022(USD Billion)
    • 7.3. Internal Radiation Therapy
      • 7.3.1. Global Internal Beam Radiotherapy market for prostate cancer, 2014 – 2022(USD Billion)
      • 7.3.2. Global Internal Beam Radiotherapy market for gynecological cancer, 2014 – 2022(USD Billion)
      • 7.3.3. Global Internal Beam Radiotherapy market for breast cancer, 2014 – 2022(USD Billion)
      • 7.3.4. Global Internal Beam Radiotherapy market for penile cancer, 2014 – 2022(USD Billion)
      • 7.3.5. Global Internal Beam Radiotherapy market for other cancers, 2014 – 2022(USD Billion)
  • Chapter 8. Global Radiotherapy Market – Regional Segment Analysis
    • 8.1. Global radiotherapy market: Regional overview
      • 8.1.1. Global radiotherapy market revenue share, by region, 2015 and 2021
    • 8.2. North America
      • 8.2.1. North America radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
      • 8.2.2. North America radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
      • 8.2.3. North America radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.2.4. U.S.
        • 8.2.4.1. U.S. radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.2.4.2. U.S. radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.2.4.3. U.S. radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
      • 8.3.2. Europe radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
      • 8.3.3. Europe radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.3.4. U.K.
        • 8.3.4.1. U.K. radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.3.4.2. U.K. radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.3.4.3. U.K. radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.3.5. Germany
        • 8.3.5.1. Germany radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.3.5.2. Germany radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.3.5.3. Germany radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.3.6.2. France radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.3.6.3. France radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
      • 8.4.2. Asia Pacific radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
      • 8.4.3. Asia Pacific radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.4.4.2. China radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.4.4.3. China radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.4.5.2. Japan radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.4.5.3. Japan radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.4.6.2. India radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.4.6.3. India radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
      • 8.5.2. Latin America radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
      • 8.5.3. Latin America radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
        • 8.5.4.2. Brazil radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
        • 8.5.4.3. Brazil radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
    • 8.6. Middle East and Africa
      • 8.6.1. Middle East and Africa radiotherapy market revenue, by product, 2014 – 2022(USD Billion)
      • 8.6.2. Middle East and Africa radiotherapy market revenue, by technology, 2014 – 2022(USD Billion)
      • 8.6.3. Middle East and Africa radiotherapy market revenue, by application, 2014 – 2022(USD Billion)
  • Chapter 9. Company Profile
    • 9.1. Elekta AB
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Varian Medical Systems
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Accuray Incorporated
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. IBA Worldwide
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. IsoRay Medical, Inc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Nordion, Inc.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Raysearch Laboratories
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Mevion Medical Systems
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Mitsubishi Electric Corporation
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Therapy portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. C. R. Bard, Inc.
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Therapy portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Radiotherapy market. Zion Research has collected and analyzed key data belong to the global Radiotherapy market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Radiotherapy across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Radiotherapy industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Radiotherapy market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Cancer can be defined as uncontrolled growth of the cell. Cancer starts when cells grow out of control and outnumber normal cells. Uncontrolled growth of cell leads to the formation of the tumor which can interfere normal cell functioning. Radiation therapy uses high-energy X-rays to destroy or injure cancer cells and to cease the growth. Radiation therapy can be used to treat cancer. About 4 out of 10 people with cancer (40%) have radiotherapy as part of their treatment. It is given in various ways, from outside the body as external radiotherapy, using X-rays from linear accelerator machines, electrons, and more rarely other particles such as protons and from within the body as internal radiotherapy, by drinking a liquid that is taken up by cancer cells or by putting radioactive material in, or close to, the tumor.

According to the American Cancer Society, cancer is the second most common cause of death in the U.S. and accounts for nearly 1 of every 4 deaths. The World Health Organization estimates that, worldwide, there were 14 million new cancer cases and 8.2 million cancer-related deaths in 2012. There are over 200 different types of cancer and each of which is classified by the type of cell that is initially affected. Various types of cancer include prostate cancer, blood cancer, lungs cancer etc. The treatment of cancer has become of prime importance owing to increase in a number of global cancer patients. Different types of drugs are administered to cancer patients depending upon therapy used to treat the patient and type of cancer.

Global-Radiotherapy-Market

Increasing prevalence of cancer across the globe is expected to be the major driver for the global radiotherapy market. In addition, increasing geriatric population coupled with large government funding is expected to trigger the growth of global radiotherapy industry in the coming years. However, lack of infrastructure coupled with the lack of skilled personnel and training may pose the challenge to radiotherapy market. Nevertheless, technological advancements in radiotherapy products coupled with the huge investment in radiotherapy across the globe are expected to act an opportunity for radiotherapy market in near future.

Based on product, radiotherapy market has been segmented into external beam radiation therapy, internal radiation therapy (brachytherapy), and systemic radiation therapy. External beam radiation therapy is further sub-segmented into compact advanced radiotherapy systems (Cyberknife, Gamma knife, and Tomotherapy), proton therapy systems (Cyclotron and Synchrotron) and electron emitting high energy linear accelerators (Linac). Internal radiation therapy is further sub-classified into seeds, applicators & after leaders and electronic brachytherapy. External beam radiation therapy holds the maximum share of global radiotherapy market.

Based on technology radiotherapy market is classified into external beam radiation therapy (Image-Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, Tomotherapy, 3D Conformal Radiotherapy (3D CRT) and Volumetric Modulated Arc Therapy (VMAT)), internal radiation therapy (Low Dose Rate and High Dose Rate), and systemic radiation therapy.

Based on applications external beam radiation therapy segment is classified into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer and other. Internal radiation therapy is classified into prostate cancer, gynecological cancer, breast cancer, penile cancer and other.

North America is expected to remain the dominant region over the forecast period. Increasing healthcare awareness is expected to boost the market in this region. Europe was the second largest market followed by Asia-Pacific. Asia-Pacific is expected to show fastest growth rate during the forecast period while Latin America market is projected to grow at a moderate rate during the forecast period. The Middle East and Africa are also expected to experience noticeable growth in the years to come.

Some of the key players in radiotherapy market include Elekta AB, Varian Medical Systems, Accuray Incorporated, IBA Worldwide, IsoRay Medical, Inc., Nordion, Inc., Raysearch Laboratories, Mevion Medical Systems, Mitsubishi Electric Corporation and C. R. Bard, Inc. among others.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com